Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate 15 Sep 2020 News
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine 30 Jul 2020 News
Sanofi and Regeneron provide update on Kevzara Phase 3 U.S. trial in COVID-19 patients 07 Jul 2020 News
Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas 24 Jun 2020 News
Sanofi invests to make France its world class center of excellence in vaccine research and production 16 Jun 2020 News
Sanofi and Regeneron provide update on U.S. Phase 2/3 trial in hospitalized COVID-19 patients 28 Apr 2020 News
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 14 Apr 2020 News